Molecular mechanisms enabling cDC2s to control Th2 cell priming
Molecular mechanisms enabling cDC2s to control Th2 cell priming
批准号:
MR/T030879/1
负责人:
Simon Milling
金额:
$68.22万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The intestine is a continuous tube that starts from the mouth and ends at the anus. It is home to the largest number of immune cells in the body. The reason for this is that the intestine is constantly exposed both to billions of harmless and beneficial microorganisms, and also to microbes that can cause infections. The immune cells in the intestine therefore face a formidable challenge. They have to recognise, attack and destroy potentially harmful infectious agents without damaging the body, but they must not mount similar attacks against food, or harmless microorganisms. These harmless materials are not just ignored, active processes are triggered to make sure that immune cells cannot respond to them and cause unnecessary damage to the body. It is important to understand how these immune responses in the intestine are controlled, so that we can find better ways to both activate these responses (e.g. for vaccination, or to control infection), and to reduce their strength when they cause damage to the intestine (e.g. during inflammatory bowel disease). The two cell types that are most important for controlling immune responses in the intestine are "dendritic cells" and "T cells". These cells interact with each other, and the outcome of this interaction defines the type of immune responses that are generated. Dendritic cells are found in the wall of the intestine, where they are able to acquire samples of proteins from their local environment, from food and microbes. After acquiring these proteins, the dendritic cells leave the intestine and travel to lymph nodes, where the T cells are found. Depending on the source of the protein the dendritic cell has acquired, the dendritic cell will cause the T cell to respond in different ways. For instance, if the dendritic cell has taken up protein from food, the T cell will be de-activated, so that an immune response is not accidentally made against a harmless food protein. On the other hand, the dendritic cell has acquired proteins from a harmful microbe, the dendritic cell will be activated by signals it will have also received from the microbe. This activated dendritic cell will then cause the responding T cell to become activated. The activated T cell will then be able to make a response against the microbe, and kill it. Different types of T cell responses are required to kill different types of microbes, so T cells activated to help kill bacteria will produce different molecules to T cells activated to help kill viruses or large parasitic organisms.This response is difficult to study because very small numbers of dendritic cell : T cell interactions have very large effects on the type of response that then occurs. It has been very challenging to discover the details of how these small numbers of dendritic cells work. By studying immune responses to parasites, we have recently identified two molecules that appear to have important effects on dendritic cell functions. Our project has two objectives. The first is to investigate how these two molecules work, and therefore understand the details of how dendritic cells control this type of immune response. Our second objective is to use methods we have developed to identify new molecules that are important for controlling immune responses in the intestine. To achieve this second objective we will take advantage of new technology that is able to identify many of the molecules produced by very small numbers of cells within larger populations. Understanding the functions of dendritic cells in the way we propose should help us to manipulate the immune response in a wide range of important situations, perhaps by improving the efficiency of vaccines, or preventing the inappropriate and damaging immune responses that cause the symptoms of inflammatory bowel disease.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A specialist antigen storage compartment in dendritic cells to sustain cross-presentation.
树突状细胞中的专门抗原储存室,用于维持交叉呈递。
DOI:
10.1111/imm.13422
发表时间:
2021
期刊:
Immunology
影响因子:
6.4
作者:
[Cerovic V]
通讯作者:
Cerovic V
DOI:
10.1038/s41385-020-0299-1
发表时间:
2020-11
期刊:
Mucosal immunology
影响因子:
8
作者:
[Clay SL, Bravo-Blas A, Wall DM, MacLeod MKL, Milling SWF]
通讯作者:
Milling SWF
DOI:
10.3389/fmicb.2021.670535
发表时间:
2021
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Carpena N, Richards K, Bello Gonzalez TDJ, Bravo-Blas A, Housden NG, Gerasimidis K, Milling SWF, Douce G, Malik DJ, Walker D]
通讯作者:
Walker D
DOI:
10.1002/eji.202048913
发表时间:
2021-12
期刊:
European journal of immunology
影响因子:
5.4
作者:
[]
通讯作者:
Mapping the Influence of the Gut Microbiota on Small Molecules across the Microbiome Gut Brain Axis.
DOI:
10.1021/jasms.1c00298
发表时间:
2022-04-06
期刊:
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
影响因子:
3.2
作者:
[Hulme, Heather, Meikle, Lynsey M., Strittmatter, Nicole, Swales, John, Hamm, Gregory, Brown, Sheila L., Milling, Simon, MacDonald, Andrew S., Goodwin, Richard J. A., Burchmore, Richard, Wall, Daniel M.]
通讯作者:
Wall, Daniel M.
共 6 条
Tissue-specific T cell migration in the intestine
-
批准号:MR/N023625/1
-
项目类别:Research Grant
-
资助金额:$94.97万
-
财政年份:2016
-
负责人:Simon Milling
-
依托单位:
How do Migratory Dendritic Cell Populations Control Immune Responses in the Intestine?
-
批准号:MR/K021095/1
-
项目类别:Research Grant
-
资助金额:$68.5万
-
财政年份:2013
-
负责人:Simon Milling
-
依托单位:
The Functions of Migrating Dendritic Cells
-
批准号:G0900270/1
-
项目类别:Research Grant
-
资助金额:$48.36万
-
财政年份:2009
-
负责人:Simon Milling
-
依托单位:
The role of intestinal lymph DCs in intiating immune responses
-
批准号:BB/D012643/2
-
项目类别:Research Grant
-
资助金额:$9.41万
-
财政年份:2008
-
负责人:Simon Milling
-
依托单位:
The role of intestinal lymph DCs in intiating immune responses
-
批准号:BB/D012643/1
-
项目类别:Research Grant
-
资助金额:$31.71万
-
财政年份:2006
-
负责人:Simon Milling
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位: